STOCK TITAN

Belgravia Hartford Capital Inc. Provides Corporate Update

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

Belgravia Hartford Capital Inc. (CSE: BLGV) has announced two key appointments to strengthen its leadership team. Ms. Ava Tahmasebi, a seasoned executive with over a decade of experience in the startup ecosystem, has been appointed as an independent director to the Board. She holds a Ph.D. in Wireless Networks and is the CEO of Startup Station, a Toronto-based startup studio focusing on women entrepreneurs.

Dr. Shoaib Sheikh, MD, FACS, has been appointed as head of the company's advisory committee. Dr. Sheikh is a surgeon with extensive experience serving on multiple boards and committees. He also owns 12.49% of Belgravia Hartford's outstanding common shares.

These appointments aim to enhance governance, provide fresh perspectives on investments, and bring global business experience to the company. The CEO, Mehdi Azodi, expressed that these additions will support the company's due diligence process and help build a new business platform while funding litigation affairs.

Loading...
Loading translation...

Positive

  • Appointment of experienced independent director Ms. Ava Tahmasebi to the Board
  • Dr. Shoaib Sheikh appointed as head of the advisory committee, bringing extensive board experience
  • Dr. Sheikh owns 12.49% of the company's outstanding common shares, indicating significant insider investment

Negative

  • None.

News Market Reaction

%
1 alert
% News Effect

On the day this news was published, BLGVF declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Toronto, Ontario--(Newsfile Corp. - August 15, 2024) - BELGRAVIA HARTFORD CAPITAL INC. (CSE: BLGV) ("Belgravia Hartford", "Belgravia" or the "Company") is pleased to announce the appointment of Ms. Ava Tahmasebi as an independent director to the Board of the Company. Additionally, Dr. Shoaib Sheikh has been appointed as head of the company's advisory committee.

Ms. Ava Tahmasebi is a seasoned executive with over a decade of experience in driving innovation and business growth within the startup ecosystem. She holds a Doctor of Philosophy (Ph.D.) in Wireless Networks and has recently updated her skills through a Data Analytics program at the University of Toronto. Ms. Tahmasebi has played a pivotal role in mentoring over 50 startups, steering them towards notable success. As CEO of Startup Station, a Toronto-based startup studio with a focus on women entrepreneurs, she has refined her expertise in transforming nascent ideas into successful, market-ready businesses. Startup Station is a member of the National Angel Capital Organization (NACO).

Dr. Shoaib Sheikh, MD, FACS, is a surgeon who has served on multiple provincial, national and international boards and committees for the past 17 years. The nature of involvement has been from board of directors, executive committees, editorial boards and provincial review committees. Dr. Sheikh has served for two full terms on the Board of Governors of the American College of Surgeons which has 90,000 member surgeons and has served on the finance committee of the College of Surgeons. Dr. Shiekh also owns 8,414,095 common shares of Belgravia Hartford which represents 12.49% of the outstanding common shares of the Company.

Mr. Mehdi Azodi, The CEO & President of Belgravia stated "The addition of Ms. Tahmasebi to the board strengthens the governance and adds fresh perspective on future investments and due diligence process. The appointment of Dr. Sheikh provides the board and legal team with global business experience and access to capital injection for the company to build out a new business platform and fund the company's litigation affairs."

About Belgravia Hartford

Belgravia Hartford Capital Inc. ("Belgravia" or the "Company") is a publicly traded investment holding company listed on the Canadian Securities Exchange. Belgravia is focused on growing its assets and holdings and increasing its net asset value (NAV). Belgravia invests in a portfolio of private and public companies located in jurisdictions governed by the rule of law. It takes a multi-sector investment approach with emphasis in the resources and commodities sector. Belgravia and its investments are considered high risk holdings and it may expose shareholders to significant volatility and losses.

For more information, please visit www.belgraviahartford.com

Forward-Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements include statements that use forward-looking terminology such as "may", "will", "expect", "anticipate", "believe", "continue", "potential" or the negative thereof or other variations thereof or comparable terminology. Such forward-looking statements include, without limitation, statements regarding planned investment activities & related returns, the timing for completion of research and development activities, the potential value of royalties, and other statements that are not historical facts. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to, changes in market trends, the completion, results and timing of research undertaken by the Company, risks associated with resource assets, the impact of general economic conditions, commodity prices, industry conditions, dependence upon regulatory, environmental, and governmental approvals, and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

For More Information, Please Contact:
Mehdi Azodi, President & CEO
Belgravia Hartford Capital Inc.
(416) 779-3268
mazodi@blgv.ca

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/220043

FAQ

Who are the new appointees to Belgravia Hartford Capital Inc. (BLGVF) leadership team?

Belgravia Hartford Capital Inc. has appointed Ms. Ava Tahmasebi as an independent director to the Board and Dr. Shoaib Sheikh as head of the company's advisory committee.

What is Ms. Ava Tahmasebi's background and role at Belgravia Hartford Capital Inc. (BLGVF)?

Ms. Ava Tahmasebi is a seasoned executive with over a decade of experience in the startup ecosystem. She holds a Ph.D. in Wireless Networks and is the CEO of Startup Station. She has been appointed as an independent director to the Board of Belgravia Hartford Capital Inc.

How many shares of Belgravia Hartford Capital Inc. (BLGVF) does Dr. Shoaib Sheikh own?

Dr. Shoaib Sheikh owns 8,414,095 common shares of Belgravia Hartford Capital Inc., which represents 12.49% of the company's outstanding common shares.

What are the expected benefits of these new appointments for Belgravia Hartford Capital Inc. (BLGVF)?

The new appointments are expected to strengthen governance, provide fresh perspectives on investments, enhance the due diligence process, bring global business experience, and support the development of a new business platform while funding litigation affairs.
Belgravia Hartford Cap Inc

OTC:BLGVF

BLGVF Rankings

BLGVF Latest News

BLGVF Stock Data

9.95M
91.44M
21.92%
Asset Management
Financial Services
Link
Canada
Kelowna